Morgan Stanley unit acquires majority stake in ClearMedi Healthcare for ₹280 crore

Morgan Stanley PE Asia acquires majority stake in ClearMedi Healthcare, India's leading cancer care chain. Navneet Bali appointed Group CEO. Morgan Stanley's entry into Indian healthcare sector a transformative moment. Bali to drive innovation, foster growth, ensure ClearMedi remains beacon of excellence. JV between Medipass, La Repubblica Group, KOS S.p.A. and Clearview Healthcare India.

Morgan Stanley PE Asia has acquired a majority stake in ClearMedi Healthcare, which runs a chain of cancer care hospitals in India, for ₹280 crore according to a statement. 

Navneet Bali, a former Indian Navy officer who had worked with healthcare companies, has been appointed as Group Chief Executive Officer (CEO) of ClearMedi Healthcare.

“Morgan Stanley’s entry into the Indian healthcare sector signifies a transformative moment for our industry. As we continue to expand and provide high-quality healthcare solutions to our patients, Commander Navneet Bali’s visionary leadership, coupled with Morgan Stanley’s support, will play a pivotal role in shaping our company’s future,” said Dr Shashi Kant Baliyan, Founder of ClearMedi Healthcare, in a statement. 

“Together with our talented team, we will drive innovation, foster growth, and ensure that ClearMedi Healthcare remains a beacon of excellence in the industry,” said Commander (Retd.) Bali in a statement. 

ClearMedi Healthcare is a joint venture between Medipass, a subsidiary of La Repubblica Group in Italy, KOS S.p.A. in Italy, and Clearview Healthcare India.